Chemo Experts, the easiest way to learn about cancer treatment
Find a Treatment:
Cancer Types

Treatment Name: Abraxane® (Paclitaxel protein-bound particles)

Abraxane® (Paclitaxel protein-bound particles) is a Chemotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)

Thank you for visiting our Abraxane® (Paclitaxel protein-bound particles) page.

  • If you are interested in seeing the full treatment regimen page for Abraxane® (Paclitaxel protein-bound particles) sooner rather than later, please cast your vote for Abraxane® (Paclitaxel protein-bound particles).
  • Votes from users like you are important as they help us prioritize the order in which we build our content. The more requests we receive, the faster we will build it!

While we work on uploading the pages that matter to you most, we hope that links to journal article references for Abraxane® (Paclitaxel protein-bound particles) shown below will prove useful in the meantime.

Thank you for your continued support!

The ChemoExperts Team


1) Green M, Manikhas G, Orlov S, et al. Abraxane®, a novel Cremophor® -free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 2006;17:1263-1268.

2) Rizvi NA, Riely GJ, Azzoli CG, et al. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer. J Clin Oncol. 2008;26:639-643.

Created: March 11, 2019 Updated: March 11, 2019

What is Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)?

What is Non-Small Cell Lung Cancer?
A disease of the tissue found in the lung.  Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Known causes include smoking and exposure to environmental toxins.  The stage of NSCLC can vary at diagnosis and throughout treatment.  Stages include stage I, II, III, and IV.  The effectiveness of the treatment may depend upon the stage at diagnosis.

NOTE: Treatment Options listed below are not all-inclusive. Other treatments may be available. ChemoExperts provides drug information and does not recommend any one treatment over another. Only your Doctor can choose which therapy is appropriate for you.

Common Abraxane® starting doses

  • Abraxane® 260 mg/m2 intravenous (I.V.) infusion over 30 minutes on Day 1 every 21 days


  • Abraxane® 125 mg/m2 I.V. infusion over 30 minutes on Days 1, 8, and 15 every 28 days